AstraZeneca Pharma India Statistics
Total Valuation
AstraZeneca Pharma India has a market cap or net worth of INR 160.64 billion. The enterprise value is 155.85 billion.
Market Cap | 160.64B |
Enterprise Value | 155.85B |
Important Dates
The next estimated earnings date is Tuesday, February 4, 2025.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.03% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 4.16M |
Valuation Ratios
The trailing PE ratio is 196.10.
PE Ratio | 196.10 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 23.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 99.36, with an EV/FCF ratio of 1,873.15.
EV / Earnings | 190.24 |
EV / Sales | 10.50 |
EV / EBITDA | 99.36 |
EV / EBIT | 114.36 |
EV / FCF | 1,873.15 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.25 |
Quick Ratio | 1.36 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.11 |
Debt / FCF | 2.06 |
Interest Coverage | 136.28 |
Financial Efficiency
Return on equity (ROE) is 12.28% and return on invested capital (ROIC) is 12.56%.
Return on Equity (ROE) | 12.28% |
Return on Assets (ROA) | 7.27% |
Return on Capital (ROIC) | 12.56% |
Revenue Per Employee | 18.56M |
Profits Per Employee | 1.02M |
Employee Count | 940 |
Asset Turnover | 1.27 |
Inventory Turnover | 2.54 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.53% in the last 52 weeks. The beta is 0.30, so AstraZeneca Pharma India's price volatility has been lower than the market average.
Beta (5Y) | 0.30 |
52-Week Price Change | +20.53% |
50-Day Moving Average | 6,937.05 |
200-Day Moving Average | 6,427.48 |
Relative Strength Index (RSI) | 35.77 |
Average Volume (20 Days) | 8,082 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AstraZeneca Pharma India had revenue of INR 14.85 billion and earned 819.20 million in profits. Earnings per share was 32.77.
Revenue | 14.85B |
Gross Profit | 6.60B |
Operating Income | 1.36B |
Pretax Income | 1.11B |
Net Income | 819.20M |
EBITDA | 1.54B |
EBIT | 1.36B |
Earnings Per Share (EPS) | 32.77 |
Balance Sheet
The company has 4.97 billion in cash and 171.20 million in debt, giving a net cash position of 4.80 billion.
Cash & Cash Equivalents | 4.97B |
Total Debt | 171.20M |
Net Cash | 4.80B |
Net Cash Per Share | n/a |
Equity (Book Value) | 6.79B |
Book Value Per Share | 271.70 |
Working Capital | 5.92B |
Cash Flow
In the last 12 months, operating cash flow was 168.70 million and capital expenditures -85.50 million, giving a free cash flow of 83.20 million.
Operating Cash Flow | 168.70M |
Capital Expenditures | -85.50M |
Free Cash Flow | 83.20M |
FCF Per Share | n/a |
Margins
Gross margin is 44.46%, with operating and profit margins of 9.18% and 5.52%.
Gross Margin | 44.46% |
Operating Margin | 9.18% |
Pretax Margin | 7.45% |
Profit Margin | 5.52% |
EBITDA Margin | 10.36% |
EBIT Margin | 9.18% |
FCF Margin | 0.56% |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.37%.
Dividend Per Share | 24.00 |
Dividend Yield | 0.37% |
Dividend Growth (YoY) | 50.00% |
Years of Dividend Growth | 2 |
Payout Ratio | 73.24% |
Buyback Yield | 0.03% |
Shareholder Yield | 0.40% |
Earnings Yield | 0.51% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |